HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
Authors Shallo SA, Tassew M
Received 19 April 2020
Accepted for publication 5 June 2020
Published 16 June 2020 Volume 2020:13 Pages 507—517
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Seifadin Ahmed Shallo,1 Mesfin Tassew2
1Department of Public Health, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia; 2Department of Pediatrics and Child Health, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia
Correspondence: Seifadin Ahmed Shallo
Department of Public Health, College of Medicine and Health Sciences, Ambo University, P.o.box-19, Ambo, Ethiopia
Tel +251 910768226
Background: Evidence from previous studies supports the idea that informing children about their HIV status has long-term positive implications in HIV disease management, children’s quality of life, and ART drug adherence. However, in sub-Saharan African Countries, the HIV status disclosure among children ranges from 0% to 69.2%. So it is important to investigate the up to date evidence that will help in designing contextualized approaches for disclosure. Therefore, this study aimed to assess the HIV status disclosure and its associated factors among children on ART in West Shoa Zone, Ethiopia.
Materials and Methods: Institutional-based observational study was conducted from February to April 2019. Quantitative data were collected from a randomly selected sample of 247 HIV positive children on ART for the last six months, and the qualitative data were collected from caregivers and health care professionals.
Results: The mean age of the children was 11.11±SD2.8, and 43.6%, (95% CI: 37, 50.9) of the children were fully disclosed. The average age at disclosure was 11±SD2.12. The main reasons for the disclosure were for drug adherence and better self-care while being underage was the commonest reason for non-disclosure. Compared to the age 10– 15 years, the child in the age 6– 9 was 97% [AOR: 0.027, 95% CI: 0.003, 0.22, P< 0.001] less likely to be disclosed. Female children were 2.7 times more likely to be disclosed compared with male children [AOR: 2.73, 95% CI: 1.24, 6, P< 0.013].
Conclusion: This finding reveals that HIV status disclosure is generally low, and the decision to disclose or not is affected by factors like child-related, caregivers, and health institution-related factors. This may affect the child’s drug adherence, treatment outcome, and disease transmission. Updating health care providers’ knowledge and skills and working on caregivers’ attitude are needed to manage disclosure and challenges following it.
Keywords: disclosure, children, West Shoa
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]